Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronnie C Mease

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Biology|February 18, 2015
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChRYongjun Gao, Ronnie C Mease, Thao T Olson, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Molecular Cancer Therapeutics|March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
PET Imaging of Accessible Prostate-Specific Membrane Antigen Reveals Dose-Dependent and Tumor Burden-Driven VariabilityAkhilesh Mishra, Ala Lisok, Ronnie C Mease, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Biomolecules|March 25, 2022
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging AgentsYing Chen, Il Minn, Steven P Rowe, et al.
Journal of Medicinal Chemistry|June 24, 2010
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
Bioconjugate Chemistry|November 20, 2012
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigenYing Chen, Mrudula Pullambhatla, Sangeeta R Banerjee, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in miceAlvaro A Ordonez, Supriya Pokkali, Vincent P DeMarco, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Biology|February 18, 2015
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChRYongjun Gao, Ronnie C Mease, Thao T Olson, et al.
Journal of Medicinal Chemistry|June 27, 2013
Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA)Sangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Molecular Cancer Therapeutics|March 29, 2011
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S)Brice A P Wilson, Haofan Wang, Benjamin A Nacev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerYing Chen, Mrudula Pullambhatla, Catherine A Foss, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2026
PET Imaging of Accessible Prostate-Specific Membrane Antigen Reveals Dose-Dependent and Tumor Burden-Driven VariabilityAkhilesh Mishra, Ala Lisok, Ronnie C Mease, et al.
Journal of Medicinal Chemistry|February 19, 2014
⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Catherine A Foss, et al.
Biomolecules|March 25, 2022
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging AgentsYing Chen, Il Minn, Steven P Rowe, et al.
Journal of Medicinal Chemistry|June 24, 2010
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancerSangeeta Ray Banerjee, Mrudula Pullambhatla, Youngjoo Byun, et al.
Bioconjugate Chemistry|November 20, 2012
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigenYing Chen, Mrudula Pullambhatla, Sangeeta R Banerjee, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2014
Radioiodinated DPA-713 imaging correlates with bactericidal activity of tuberculosis treatments in miceAlvaro A Ordonez, Supriya Pokkali, Vincent P DeMarco, et al.
Pageof 8